HNWAG
MIRM icon

High Net Worth Advisory Group’s Mirum Pharmaceuticals MIRM Stock Holding History

High Net Worth Advisory Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$32K – 666
2022
Q3 		$32K Hold
1,500
– – 0.01% 401
2022
Q2 		$29K Hold
1,500
– – 0.01% 398
2022
Q1 		$33K Hold
1,500
– – 0.01% 391
2021
Q4 		$24K Buy
+1,500
New +$23.3K 0.01% 438

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

High Net Worth Advisory Group's MIRM Position: Q4 2022 in Review

High Net Worth Advisory Group sold out of Mirum Pharmaceuticals (MIRM) in Q4 2022, closing a stake of 1,500 shares — an estimated $32K sold.

High Net Worth Advisory Group first reported a position in MIRM in Q4 2021 and held it in 4 quarters. The position peaked at $33K in Q1 2022. 104 funds tracked by Wall St. Rank hold MIRM as of Q4 2022.

  • High Net Worth Advisory Group reported no remaining Mirum Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 1,500 Mirum Pharmaceuticals shares in Q4 2022, an estimated $32K.
  • High Net Worth Advisory Group first reported a position in Mirum Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • High Net Worth Advisory Group's Mirum Pharmaceuticals position peaked at $33K in Q1 2022.
  • 104 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2022.

Based on High Net Worth Advisory Group's 13F filing for Q4 2022, filed 14 Feb 2023.